84 related articles for article (PubMed ID: 4744592)
21. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
[No Abstract] [Full Text] [Related]
22. [Hodgkin's disease. Lymphoadenography, cupremia and sideremia].
Weissleder H; Marongiu F
Prensa Med Argent; 1966 May; 53(18):1001-7. PubMed ID: 5916206
[No Abstract] [Full Text] [Related]
23. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
Jamakovic M; Baljic R
Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
25. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of the blood copper in Hodgkin's disease.
PAGLIARDI E; GIANGRANDI E
Acta Haematol; 1960 Oct; 24():201-12. PubMed ID: 13732060
[No Abstract] [Full Text] [Related]
27. Prognostic factors in 454 cases of Hodgkin's disease.
Tubiana M; Attié E; Flamant R; Gérard-Marchant R; Hayat M
Cancer Res; 1971 Nov; 31(11):1801-10. PubMed ID: 5121686
[No Abstract] [Full Text] [Related]
28. Prognostic significance of serum albumin in Hodgkin's disease.
Gobbi PG; Cavalli C; Gendarini A; Bonfichi M; Galeone F; Inzoli A; Ascari E
Haematologica; 1986; 71(2):95-102. PubMed ID: 3087839
[No Abstract] [Full Text] [Related]
29. Hodgkin's disease: a follow-up study of patients surviving more than twenty years after the original diagnosis.
Smetana HF
J Pathol; 1969 Aug; 98(4):231-40. PubMed ID: 5358275
[No Abstract] [Full Text] [Related]
30. [Zinc and copper blood levels in patients with Hodgkin's disease].
Adamczyk B; Glińska H; Kulpa J; Pawlicki M
Nowotwory; 1974; 24(1):9-15. PubMed ID: 4824380
[No Abstract] [Full Text] [Related]
31. [Fibrinogen in Hodgkin's disease].
Hlousková D; Hermanská Z; Foltýnová V; Barták P; Maríková E
Sb Lek; 1986 Jul; 88(7):199-202. PubMed ID: 3738409
[No Abstract] [Full Text] [Related]
32. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic value of beta-2-microglobulin in Hodgkin disease in young adults].
Fleury J; Tortochaux J; Legros M; Cure H; Kwiatkowski F; Ferrière JP; Travade P; Dionet C; Gaillard G; Chassagne J
Bull Cancer; 1994 Jul; 81(7):625-31. PubMed ID: 7742606
[TBL] [Abstract][Full Text] [Related]
34. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic value of copper and magnesium in hemolymphopathies and solid tumors].
Russo N; Cipolletta L; Diadema MR; Parente A; Lonardo L
Minerva Med; 1981 May; 72(21):1331-8. PubMed ID: 7231784
[TBL] [Abstract][Full Text] [Related]
36. Letter: Serum-copper in Hodgkin's disease before and after herpes zoster.
Thorling EB; Thorling K
Lancet; 1974 Dec; 2(7893):1396-7. PubMed ID: 4143363
[No Abstract] [Full Text] [Related]
37. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
38. [Hepatic localizations of Hodgkin's disease].
Hoerni B; Leleu JP; Durand M; Chauvergne J
Med Chir Dig; 1973; 2(6):333-6. PubMed ID: 4792027
[No Abstract] [Full Text] [Related]
39. Prognosis in Hodgkin's disease: verification of a new predictive equation.
Bettini R; Quadrelli M; Quadrelli G; Biganzoli L; Venco A
Haematologica; 1990; 75(5):482. PubMed ID: 2097268
[No Abstract] [Full Text] [Related]
40. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA
Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
